Chemotherapy with alkylating agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Tumor Cells, Cultured Bone Marrow Cell Line CHO Cells Ovary

Organisms4

Cricetinae Cricetulus Escherichia coli Mice, Nude

Diseases58

Breast Neoplasms Neoplasms Brain Neoplasms Lung Neoplasms Neoplasms, Second Primary Neoplasm Recurrence, Local Hodgkin Disease Glioma Ovarian Neoplasms Leukopenia Glioblastoma Sarcoma, Yoshida Leukemia, Radiation-Induced Lymphoma, Non-Hodgkin Neutropenia Leukemia L1210 Adenocarcinoma Lymphoma Neoplasm Metastasis Myelodysplastic Syndromes Carcinoma, Non-Small-Cell Lung Leukemia, Myeloid Leukemia L5178 Multiple Myeloma Leukemia Testicular Neoplasms Waldenstrom Macroglobulinemia Leukemia, Myeloid, Acute Vomiting Nausea Thrombocytopenia Oligodendroglioma Recurrence Neoplasms, Experimental Colorectal Neoplasms Disease Progression Neoplasms, Germ Cell and Embryonal Leukemia P388 Bone Neoplasms Primary Ovarian Insufficiency Chromosome Aberrations Osteosarcoma Leukemia, Lymphocytic, Chronic, B-Cell Fibrosarcoma Melanoma Carcinoma 256, Walker Liver Neoplasms Peritoneal Neoplasms Carcinoma Carcinoma, Squamous Cell Lymphatic Metastasis Stomach Neoplasms Rhabdomyosarcoma Germinoma Colonic Neoplasms Astrocytoma Sarcoma Precursor Cell Lymphoblastic Leukemia-Lymphoma

Chemicals and Drugs122

Alkylating Agents Antineoplastic Agents, Alkylating O(6)-Methylguanine-DNA Methyltransferase Methylnitronitrosoguanidine Carmustine Cyclophosphamide Methyl Methanesulfonate Antineoplastic Agents Mechlorethamine Chlorambucil Dacarbazine Cisplatin Melphalan Ethyl Methanesulfonate Nitrogen Mustard Compounds Doxorubicin Thiotepa Guanine Methylnitrosourea Etoposide Nitrosourea Compounds Sulfuric Acid Esters Mitomycin Mutagens Ethylnitrosourea Mitomycins Methyltransferases Lomustine Ifosfamide Phosphoramide Mustards Methotrexate Carboplatin Triaziquone Vinblastine Bleomycin Aziridines Mustard Gas Nimustine Paclitaxel DNA Modification Methylases Etanidazole Organoplatinum Compounds DNA Glycosylases Antimetabolites, Antineoplastic DNA Repair Enzymes DNA Antibiotics, Antineoplastic Propiolactone Cytarabine Ethylmaleimide Taxoids Nylons DNA Adducts Anthracyclines Methionine Sulfoximine Deoxycytidine Porfiromycin Antineoplastic Agents, Phytogenic Mesylates Busulfan Quinacrine Mustard Dicumarol Buthionine Sulfoximine DNA, Neoplasm N-Glycosyl Hydrolases Poly(ADP-ribose) Polymerases 4-Nitroquinoline-1-oxide Semustine Camptothecin Granulocyte Colony-Stimulating Factor Iodoacetamide Podophyllotoxin Cyclohexenes Carcinogens Glutathione Nitroimidazoles Mitolactol Cross-Linking Reagents Poly Adenosine Diphosphate Ribose Thioguanine DNA-(Apurinic or Apyrimidinic Site) Lyase Tumor Markers, Biological Hydrazines Hydrocarbons, Brominated Netropsin Vidarabine Sulfhydryl Compounds Topoisomerase II Inhibitors Topoisomerase Inhibitors Epoxy Compounds Antibodies, Monoclonal Glutathione Transferase Novobiocin Platinum Compounds Amifostine Reducing Agents Aniline Mustard Vinca Alkaloids Antiemetics Distamycins Vincristine Prednisolone Misonidazole Apurinic Acid Antibodies, Monoclonal, Murine-Derived Tumor Suppressor Protein p53 DNA-Binding Proteins Mitoxantrone Epichlorohydrin Tegafur Antibodies, Monoclonal, Humanized Recombinant Proteins Chemical Warfare Agents Teniposide Deoxyribonuclease IV (Phage T4-Induced)P-Glycoprotein Carbon-Oxygen Lyases Cysteine Dexamethasone Daunorubicin Radiation-Sensitizing Agents Prodrugs

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant Combined Modality Therapy Treatment Outcome Disease-Free Survival Drug Administration Schedule Survival Analysis Neoadjuvant Therapy Neoplasm Staging Prognosis Survival Rate Radiotherapy Induction Chemotherapy Drug Screening Assays, Antitumor Salvage Therapy Transplantation, Autologous Follow-Up Studies Clinical Trials as Topic Chemotherapy, Cancer, Regional Perfusion Hematopoietic Stem Cell Transplantation Infusions, Intravenous Prospective Studies Drug Evaluation Actuarial Analysis Radiotherapy, Adjuvant Neoplasms, Experimental Bone Marrow Transplantation Mutagenicity Tests Kaplan-Meier Estimate Radiotherapy Dosage Infusions, Intra-Arterial Tumor Stem Cell Assay Xenograft Model Antitumor Assays Drug Therapy Randomized Controlled Trials as Topic Palliative Care Neoplasm Transplantation Immunohistochemistry Comet Assay Risk Factors

Phenomena and Processes22

Alkylation DNA Repair DNA Damage Drug Resistance, Neoplasm Drug Resistance Dose-Response Relationship, Drug Cell Survival Drug Synergism Time Factors DNA Adducts Mutation Apoptosis Kinetics Ultraviolet Rays Base Pair Mismatch Base Sequence Chromosome Aberrations Cell Cycle Biotransformation Drug Resistance, Multiple Gene Expression Regulation, Neoplastic Sister Chromatid Exchange

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture2

Nylons Chemical Warfare Agents

Information Science3

Survival Rate Molecular Sequence Data Base Sequence

Named Groups1

Health Care13

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Clinical Trials as Topic Prospective Studies Actuarial Analysis Ultraviolet Rays Kaplan-Meier Estimate Randomized Controlled Trials as Topic Palliative Care Risk Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care

Alkylating Agents Antineoplastic Agents, Alkylating Antineoplastic Combined Chemotherapy Protocols Chemotherapy, Adjuvant O(6)-Methylguanine-DNA Methyltransferase Alkylation Methylnitronitrosoguanidine Carmustine Cyclophosphamide Methyl Methanesulfonate Antineoplastic Agents Mechlorethamine Chlorambucil Dacarbazine Cisplatin Melphalan Combined Modality Therapy Ethyl Methanesulfonate Nitrogen Mustard Compounds Doxorubicin DNA Repair Treatment Outcome Thiotepa DNA Damage Guanine Methylnitrosourea Drug Resistance, Neoplasm Disease-Free Survival Etoposide Nitrosourea Compounds Breast Neoplasms Sulfuric Acid Esters Mitomycin Drug Administration Schedule Mutagens Survival Analysis Ethylnitrosourea Neoadjuvant Therapy Mitomycins Drug Resistance Methyltransferases Lomustine Ifosfamide Neoplasm Staging Prognosis Phosphoramide Mustards Neoplasms Dose-Response Relationship, Drug Methotrexate Survival Rate Brain Neoplasms Lung Neoplasms Cell Survival Carboplatin Triaziquone Vinblastine Radiotherapy Bleomycin Aziridines Neoplasms, Second Primary Mustard Gas Nimustine Paclitaxel DNA Modification Methylases Etanidazole Organoplatinum Compounds Drug Synergism Neoplasm Recurrence, Local DNA Glycosylases Hodgkin Disease Time Factors Antimetabolites, Antineoplastic DNA Repair Enzymes Glioma DNA Antibiotics, Antineoplastic Propiolactone Cytarabine Induction Chemotherapy Drug Screening Assays, Antitumor Salvage Therapy Ovarian Neoplasms Ethylmaleimide Leukopenia Transplantation, Autologous Cell Line, Tumor Tumor Cells, Cultured Taxoids Nylons Glioblastoma Sarcoma, Yoshida Follow-Up Studies Leukemia, Radiation-Induced DNA Adducts Lymphoma, Non-Hodgkin Mutation Anthracyclines Methionine Sulfoximine Cricetinae Deoxycytidine

No FAQ available that match "chemotherapy with alkylating agents"